RE: CICC9 Dec 2025 11:02
Innomed Tech Ltd.
Corporate Update
Innomed Tech Ltd. (BC, Canada) (the “Company”) is pleased to announce the following corporate update.
Progress of listing on the TSX Venture Exchange (TSXV)
The Company’s listing application has been conditionally accepted by TSX Venture Exchange Inc. (the
“Exchange”). The Exchange’s conditional acceptance is provided based on the Company meeting Initial Listing
Requirements to be listed as a Tier 2 Industrial Issuer, by March 2nd, 2026. The Company is working with the
TSXV to address the outstanding matters and complete its listing.
Formal Issue of Electronic Common Shares
The Company has completed the common share issue by Computershare to all shareholders, excluding escrowed
and restricted common shares. The Company will advise shareholders of the possible trading date should it be
approved by the TSXV.
Patents and Awards
Following the EU patent award and numerous other jurisdiction awards, the Company will focus on pursuing the
US patent application with Office Freylinger Luxembourg. Patent protection in major markets protects the
Company’s intellectual property and strengthens future distribution contracts.
PureFlowCath Catheter to Market Development
The Company is finalising the working protocols and arrangements with Cambridge Consultants Limited that
follows the US Federal Drug Authority “Recommended Waterfall Medical Device Design Process to Market”, as
reviewed by Clark Regulatory.
Mr. Robert Rhodes
WWW.Innomedtec.com
Innomed Tech Ltd.
rrhodes@innomedtec.com
The Company’s first medical device development subsidiary, PureFlowCath, is developing the PureFlowCath
Catheter System to provide continuous irrigation (“CSCI) with the objective of reducing urinary tract infections
commonly associated with the use of a urinary catheter.
Catheter-associated urinary tract infection (CAUTI) is the most frequent healthcare-associated infection worldwide
accounting for up to 40% of all hospital-acquired infections and resulting in over 13,000 deaths annually in the
United States alone, according to data from the Centres for Disease Control and Prevention.
Sign In
Follow the stocks
